2016 Cord Blood Workshop Presentations

Please note: Only those presentations where permission has been received for posting are available to meeting delegates. A large number of speakers are in the process of providing ISCT with revised slides and as a result, these presentations will be gradually uploaded to the website as they are received.

Reference to these materials will be useful but not comprehensive in developing appropriate standards of care. Their use does not confer any professional qualification or standard. Publication of these materials does not constitute an endorsement of ISCT. ISCT has not reviewed these materials to ensure consistency with acceptable practices. The views expressed in these materials represent the opinion of the authors. ISCT expressly disclaims any liability arising from any inaccuracy or misstatement. Each facility and/or individual referring to these materials should analyze the information, practices and procedures outlined therein to determine their acceptability for use in the context of their own obligations and within their own facility's standards and procedures.

Speakers for the following presentations have given authorization to post their materials.

Presentations are continually being added. Please check back regularly.


Session I
Novel Approaches to Cell Engineering 
Mahendra Rao, Q Therapeutics, Inc. – Using Safe Harbor Gene Engineering to Enhance Cell Therapy with Cord Blood and Cord Tissue 
Colleen Delaney, Fred Hutchinson Cancer Research Center – Universal Donor Expanded Cord Blood Stem/Progenitor Cells to Enhance Engraftment: It isn't all about the Neutrophil 
Elizabeth J. Shpall, MD Anderson Cancer Center – Enhancing Cord Blood Engraftment and Abrogation of GVHD
Iddo Peleg, Gamida Cell Ltd. – NiCord from Bench to Phase III: The Trials and Tribulations of Bringing a Single Expanded Cord Unit to a Randomized Trial 

Session II
Cord Blood Derived Immunotherapies for Cancer and Infection
Catherine Bollard, The George Washington University – Cord Blood Derived T-Cells for Virus Infection
Katy Rezvani, MD Anderson Cancer Center – Engineered Cord Blood Derived Natural Killer Cells as a Source of Off-the-Shelf Cellular Immunotherapy for Cancer
Helen Heslop, Baylor College of Medicine – Third Party Virus Specific T Cells 

Session III
Stem Cell Regenerative Therapies for Lung Disease
Daniel Chambers, The Prince Charles Hospital – Idiopathic Pulmonary Fibrosis – A Degenerative Disease in Need of a Regenerative Solution 
Amanda Olson, MD Anderson Cancer Center – Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome 

Session IV
Stem Cell Regenerative Therapies for Neurological Diseases
Joanne Kurtzberg, Duke University Medical Center – Healing the Brain with Umbilical Cord Blood Cells 
Jaap Boelens, UMC Utrecht – Cord Blood Transplantation in Lysosomal Storage Diseases

Closing Panel 
The Future of Cord Blood Banking in the Emerging World of Regenerative Medicine 
Moderators: Elizabeth J. Shpall, MD Anderson Cancer Center and Joanne Kurtzberg, Duke University Medical Center 
International Society for Cellular Therapy
Cord Blood Association


© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.